Secondary leukemias and leukeogenesis


Published: June 11, 2009
Abstract Views: 407
PDF: 155
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The last annual combined report from the American Cancer Society, NCI, CDC and NAACCR provided information on cancer rates and trends in United States from 1975 to 2002. This survey showed that among men the incidence rates for all cancer were stable, while among women they increased by 0.3% annually. On the other hand the overall cancer death rates decreased by 1.1% from 1993 through 2002.1 On this basis, there is a high number of patients surviving at long-term, at risk to develop a secondary acute myeloid leukemia or myelodysplastic syndromes (t-AML/ MDS).

Supporting Agencies


Leone, G., Voso, M. T., & Pagano, L. (2009). Secondary leukemias and leukeogenesis. Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.512

Downloads

Citations